Neuropeptide S (human) (TFA)

Research use only, not for human use.

Neuropeptide S human (TFA) is a potent endogenous neuropeptide S receptor agonist (EC50=9.4 nM).

Neuropeptide S human (TFA) is a potent endogenous neuropeptide S receptor agonist (EC50=9.4 nM). (In Vitro):Neuropeptide S (human)(4 pM to 1.7 nM; 48 hours) retains full agonist activity with an EC50 of 6.7 ± 2.4 nM, the binding of [125I] Y10-hNPS to CHO cells stably expressing hNPSR is saturable with high affinity (Kd = 0.33 ± 0.12 nM). Neuropeptide S (human)(1 pM-3 μM; 48 hours) are used to compete with 0.15 nM [125II] Y10-NPS, [125II] Y10-NPS is displaceable by increasing concentrations of human NPS (IC50 = 0.42 ± 0.12 nM) .(In Vivo):Neuropeptide S human (TFA)(intracerebroventricular (i.c.v.) injection; 0.1 nM or 1 nM; 60 mins) causes a significant increase in locomotor activity, the total distance traveled, percentage of time moving, number of rearing events, and center entries are also significantly increased in mice.

——

——

——

Others

Other Targets

EC50: 9.4 nM (neuropeptide S receptor)

——

——

——

2301.52

C95H156N31F3O30S

>98% (HPLC)

——

——

Sequence:{Ser}{Phe}{Arg}{Asn}{Gly}{Val}{Gly}{Thr}{Gly}{Met}{Lys}{Lys}{Thr}{Ser}{Phe}{Gln}{Arg}{Ala}{Lys}{Ser}

(-20℃)

With Ice Pack

≥ 2 years